A global healthcare company needed specific equipment for a project at their Ridgefield, New Jersey facility. The project involved the expedited procurement of a renester machine for the renesting of 1 ml long syringes. Facing a tight deadline, the Global Lead Buyer contacted EquipNet to explore alternative procurement options for the necessary equipment.

Having initially explored purchasing a new Renester machine directly from the manufacturer, the lead time for a new machine was prohibitively long—estimated at 16 to 18 months. Their project required the machine to be operational by January 2024, leaving them less than two months to source, purchase, and install the equipment.

EquipNet quickly identified a potential solution by leveraging its global presence. A complete syringe line, including the desired Inova (Optima) SH-20 Renester machine, was available for sale from a biotech company based in Illinois. EquipNet’s team contacted the head of engineering of the client company to confirm the machine’s suitability for their needs. After reviewing the available equipment, there was an expressed interest in purchasing the Renester.

To meet the budget and timeline requirements, EquipNet negotiated with the seller to sell the Renester as a standalone unit, separate from the complete syringe line. They agreed, and EquipNet facilitated discussions between both parties to ensure all were aligned on the equipment specifications and maintenance history. After these conversations, the client decided to move forward with an offer of $100,000, contingent on the machine having a guaranteed delivery by the end of January 2024.

EquipNet successfully negotiated the sale, securing an agreement to the $100,000 offer by mid-December 2023. Despite the seller undergoing a holiday shutdown, EquipNet’s logistics team coordinated and used an approved vendor to ensure the removal, packing, loading, and shipment of the Renester machine to the client’s site in Ridgefield. Thanks to these efforts, the machine was delivered and installed before the critical end-of-January deadline for a cost well below the market value of a new machine estimated to be within the $300k – $350k range.